These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1881946)

  • 1. Verapamil and the synthesis of prostacyclin in human veins.
    Fahr A; Langer R; Sziegoleit W; Blauschmidt J; Albert H; Liebal H; Mest HJ
    Pharmazie; 1991 Mar; 46(3):213-4. PubMed ID: 1881946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pentoxifylline administered in vivo on the synthesis of PGI2 in human varicose veins.
    Fahr A; Langer R; Sziegoleit W; Albert H; Liebal H; Mest HJ
    Biomed Biochim Acta; 1988; 47(10-11):S238-40. PubMed ID: 3073763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of indometacin administered in vivo on the synthesis of PGI2-like substances in human veins.
    Fahr A; Langer R; Sziegoleit W
    Biomed Biochim Acta; 1984; 43(8-9):S451-4. PubMed ID: 6393975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo injection of dipyridamole stimulates the synthesis of prostacyclin-like substances in human varicose veins.
    Fahr A; Langer R; Sziegoleit W; Beitz J; Krause P; Förster W
    Biomed Biochim Acta; 1984; 43(3):K6-8. PubMed ID: 6378192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human platelet functions by verapamil.
    Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo.
    Strano A; Davì G; Novo S; Custro N; Mattina A; Gallo V
    Int Angiol; 1985; 4(3):379-82. PubMed ID: 3913716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prostacyclin production from human veins by dipyridamole: an in vitro and ex vivo study.
    Costantini V; Talpacci A; Bastiano ML; Boschetti E; Cipolloni S; Bisacci R; Nenci GG
    Biomed Biochim Acta; 1990; 49(4):263-71. PubMed ID: 2119575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of calcium antagonists on platelet function and vascular prostacyclin production.
    Pirich C; Schmid P; Fitscha P; Wytek R; O'Grady J; Sinzinger H
    Blood Press Suppl; 1994; 1():75-80. PubMed ID: 8205307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is the tonisation of varicose veins due to elevated prostacyclin synthesis caused by dihydroergotamine?].
    Sinzinger H; Feigl W
    Wien Klin Wochenschr; 1985 Nov; 97(21):817-9. PubMed ID: 3904225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H; Kimura M
    Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of the venous wall--platelet interaction by dihydroergotamine (author's transl)].
    Silberbauer K; Fitscha P; Sinzinger H
    Wien Klin Wochenschr; 1981 Oct; 93(18):577-9. PubMed ID: 7029927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of salicylate to reduce inhibition of human venous prostacyclin in synthesis by conventional dose aspirin.
    Hanley SP; Hughes J
    Thromb Haemost; 1983 Feb; 49(1):51-2. PubMed ID: 6342201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced prostacyclin formation in veins of women under chronical treatment with oral contraceptive drugs.
    Sinzinger H; Klein K; Kaliman J; Silberbauer K; Feigl W
    Pharmacol Res Commun; 1980 Jun; 12(6):515-21. PubMed ID: 6995996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in platelet response to adenosine 5'-diphosphate caused by verapamil.
    Walkowiak B; Koziołkiewicz W; Michalec L; Pawłowska Z; Krzesłowska J; Cierniewski CS
    Pol J Pharmacol; 1996; 48(3):303-5. PubMed ID: 9112667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
    Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats.
    Leithner C; Winter M; Silbauer K; Wagner O; Pinggera W; Sinzinger H
    Proc Eur Dial Transplant Assoc; 1978; 15():418-23. PubMed ID: 368786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
    Matzky R; Darius H; Schrör K
    Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.